HOPE Demonstration Field Experiment Multisite Evaluation

December 13, 2017 updated by: RTI International

Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment

The purpose of the Multisite Evaluation of the Honest Opportunity Probation with Enforcement Demonstration Field Experiment (the HOPE DFE Evaluation) is to conduct a randomized control trial (RCT) replication of the original Hawaii HOPE program and evaluation. The HOPE program provides strict oversight of probationers through a HOPE Court judge and intensive probation supervision, including random drug testing, coupled with swift and certain sanctions in response to positive results on random drug tests and other violations of conditions of supervision. The HOPE DFE Evaluation is being conducted among probation populations in four sites and will identify the effectiveness of swift and certain sanctions on targeted outcomes, both primary (appointment no-shows, positive urine tests, re-arrest rates) and secondary (revocation rates, jail days served, prison days sentenced).

Study Overview

Detailed Description

The Multisite Evaluation of the Honest Opportunity Probation with Enforcement Demonstration Field Experiment (the HOPE DFE Evaluation) has four goals: (1) Design and implement a randomization process in each of the four DFE sites; (2) Conduct a comprehensive process evaluation to assess implementation fidelity and identify lessons learned that will enhance future replications; (3) Conduct a rigorous experimental outcome evaluation to determine the effect of the HOPE model and its components on individual probation outcomes; and (4) Conduct a cost evaluation to assess the cost effectiveness of HOPE. The RCT will involve identifying in each of four sites a pool of HOPE-eligible probationers who will be randomly assigned to HOPE or to probation as usual (PAU). The evaluation will randomly assign approximately 400 eligible probationers to HOPE or PAU in each of the four sites for a total sample size of 1,600 (800 HOPE and 800 PAU). Criteria identifying the HOPE-eligible target population and procedures to identify that population in a timely fashion randomly assigning HOPE-eligible Probationers to HOPE or PAU have been identified. Random assignment will be accomplished using evaluation-provided forms that include study identification numbers and the random assignment that is covered by a scratch-off label. The assignment will be revealed only after the individual has been provided the opportunity to participate in the evaluation and, with consent, completed the baseline interview. The process evaluation/fidelity assessment component will document the extent to which each program conforms to the HOPE model; document the barriers, challenges, facilitators, and lessons learned during implementation to fill gaps in the knowledge base as to what is required to set up a HOPE program; and provide evidence as to the generalizability and sustainability of HOPE programs. This component will also document the PAU control conditions in each site and will assess implementation fidelity of evidence-based drug treatment programs. Implementation and process measures will be collected through stakeholder interviews; observation of initial warning hearings and court appearances; and review of court, probation, and HOPE project records. The process evaluation will also document the PAU practices to identify intervention differences among the control groups and to provide an opportunity to measure changes in practices that could signal contamination of the control arm. Fidelity assessments of drug treatment programs will be conducted using the Correctional Program Checklist. The outcome study will assess whether HOPE participation improves appointment compliance, drug test results, rearrest rates, revocation rates, jail days served, and prison days sentenced. In addition, the evaluation will determine whether HOPE participation changes potential mediators including criminal thinking/attitudes, perceptions of control and justice system fairness and legitimacy, dynamic recidivism risk factors, and employment and housing stability. For the outcome study, administrative data will provide information on appointment compliance, drug test results, re-arrests, violations, revocations, and jail and prison days for all HOPE and PAU evaluation participants. Interview data will be collected from evaluation participants at evaluation enrollment and 6 months post-enrollment on measures that will facilitate understanding of the nature of individual change associated with HOPE participation. All HOPE-eligible Probationers who consent to study participation will complete an audio computer assisted self interview (ACASI) at baseline and 6 months post baseline; a random sample of those completing ACASI baseline interviews will be asked to participate in a twice-weekly series of mini-interviews (telephone-ACASI or T-ACASI). Non-incarcerated individuals are being offered $20 equivalent to complete the ACASI interview. Random drug tests on a subsample of HOPE and PAU evaluation participants will be conducted in conjunction with the 6-month post-enrollment interviews to provide a common measure of current drug use.

Study Type

Interventional

Enrollment (Actual)

1504

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arkansas
      • Benton, Arkansas, United States
        • Court and Probation Office, Saline County
    • Massachusetts
      • Salem, Massachusetts, United States
        • Salem County Probation Office, Massachusetts Salem District Court, Essex County Superior Court
    • Oregon
      • Oregon City, Oregon, United States
        • Court and Probation Office
    • Texas
      • Fort Worth, Texas, United States
        • Court and Probation Office, Tarrant County

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult probationers assessed as high risk for failure on probation (e.g., high likelihood of new arrest, failure to comply with conditions) who live within the geographic boundaries of the study site with at least 11.5 months remaining on their probation sentence

Exclusion Criteria:

  • Juveniles
  • live outside geographic boundaries
  • assigned to specialized probation caseloads (e.g., sex offender, DUI, mental health)
  • non-English speaking in some sites

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HOPE
Participation in HOPE program
HOPE Court Judge provides warning hearing; random drug testing; violation hearing and jail/other sanctions for failed drug test or failure to comply with other probation conditions.
Active Comparator: Probation as Usual
Participation in probation as usual
Probation officer supervises following standard protocols.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Illegal drug use
Time Frame: 6 months
Multiple measures to include percent positive for (1) marijuana, (2) cocaine, (3) heroin, (4) methamphetamine, and (5) any illegal drug on an oral swab drug test administered in conjunction with the 6 month follow-up interview (subjects in the community, i.e. not jailed or institutionalized, only).
6 months
Rearrest
Time Frame: 6 Months
Multiple measures to include (1) percent arrested within 6 months of baseline; (2) time to first (and subsequent) arrests following baseline; (3) number of arrests following baseline (variable follow-up period depending upon baseline date); (4) number of arrests within 6 months of baseline; and (5) percent arrested for (a) violent, and (b) property
6 Months
Rearrest
Time Frame: 12 months
Multiple measures to include (1) percent arrested within 12 months of baseline; (2) time to first (and subsequent) arrests following baseline; (3) number of arrests following baseline (variable follow-up period depending upon baseline date); (4) number of arrests within 12 months of baseline; and (5) percent arrested for (a) violent, (b) property, and (c) drug offenses within 12 months of baseline.
12 months
Probation Appointment Compliance
Time Frame: 6 months
Number of missed appointments following baseline.
6 months
Probation Appointment Compliance
Time Frame: 12 months
Number of missed appointments following baseline.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probation revocation
Time Frame: 6 months
Percent revoked from probation within 6 months following baseline.
6 months
jail days served
Time Frame: 6 months
Number of days served in jail within 6 months following baseline for (1) violation of conditions of probation; (2) arrest or charge for new offense; (3) sentence for new offense; and (4) total number of days.
6 months
Probation Revocation
Time Frame: 12 Months
Percent revoked from probation within 12 months following baseline.
12 Months
Jail Days Served
Time Frame: 12 months
Number of days served in jail within 12 months following baseline for (1) violation of conditions of probation; (2) arrest or charge for new offense; (3) sentence for new offense; and (4) total number of days.
12 months
Prison Days Sentenced
Time Frame: 6 months
Number of days sentenced to prison within 6 months following baseline for (1) probation revocation; (2) conviction for a new offense; and (3) total of revocation and new conviction.
6 months
Prison Days Sentenced
Time Frame: 12 months
Number of days sentenced to prison within 12 months following baseline for (1) probation revocation; (2) conviction for a new offense; and (3) total of revocation and new conviction.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pamela K Lattimore, PhD, RTI International

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2012

Primary Completion (Actual)

March 31, 2015

Study Completion (Actual)

March 31, 2015

Study Registration Dates

First Submitted

August 7, 2012

First Submitted That Met QC Criteria

August 20, 2012

First Posted (Estimate)

August 22, 2012

Study Record Updates

Last Update Posted (Actual)

December 15, 2017

Last Update Submitted That Met QC Criteria

December 13, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2011-RY-BX-0003

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on HOPE

3
Subscribe